WO2019125313A1 - Burn treatment cream and production method thereof - Google Patents
Burn treatment cream and production method thereof Download PDFInfo
- Publication number
- WO2019125313A1 WO2019125313A1 PCT/TR2017/050736 TR2017050736W WO2019125313A1 WO 2019125313 A1 WO2019125313 A1 WO 2019125313A1 TR 2017050736 W TR2017050736 W TR 2017050736W WO 2019125313 A1 WO2019125313 A1 WO 2019125313A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- oil
- cream
- production method
- egg yolk
- weight
- Prior art date
Links
- 239000006071 cream Substances 0.000 title claims abstract description 20
- 238000011282 treatment Methods 0.000 title claims abstract description 16
- 238000004519 manufacturing process Methods 0.000 title claims description 9
- 102000002322 Egg Proteins Human genes 0.000 claims abstract description 16
- 108010000912 Egg Proteins Proteins 0.000 claims abstract description 16
- 235000013345 egg yolk Nutrition 0.000 claims abstract description 16
- 210000002969 egg yolk Anatomy 0.000 claims abstract description 16
- 235000021323 fish oil Nutrition 0.000 claims abstract description 16
- 239000003921 oil Substances 0.000 claims abstract description 14
- 235000019198 oils Nutrition 0.000 claims abstract description 14
- 239000002674 ointment Substances 0.000 claims abstract description 14
- 239000004006 olive oil Substances 0.000 claims abstract description 14
- 235000008390 olive oil Nutrition 0.000 claims abstract description 14
- ZZVUWRFHKOJYTH-UHFFFAOYSA-N diphenhydramine Chemical compound C=1C=CC=CC=1C(OCCN(C)C)C1=CC=CC=C1 ZZVUWRFHKOJYTH-UHFFFAOYSA-N 0.000 claims abstract description 13
- 229960000520 diphenhydramine Drugs 0.000 claims abstract description 13
- FDDDEECHVMSUSB-UHFFFAOYSA-N sulfanilamide Chemical compound NC1=CC=C(S(N)(=O)=O)C=C1 FDDDEECHVMSUSB-UHFFFAOYSA-N 0.000 claims abstract description 13
- 229940124530 sulfonamide Drugs 0.000 claims abstract description 13
- 239000010698 whale oil Substances 0.000 claims abstract description 12
- 206010006802 Burns second degree Diseases 0.000 claims abstract description 8
- 206010006803 Burns third degree Diseases 0.000 claims abstract description 8
- 206010006797 Burns first degree Diseases 0.000 claims abstract description 7
- 208000009043 Chemical Burns Diseases 0.000 claims abstract description 5
- 239000001993 wax Substances 0.000 claims description 12
- 239000000126 substance Substances 0.000 claims description 8
- 238000000034 method Methods 0.000 claims description 6
- 238000010438 heat treatment Methods 0.000 claims description 4
- 235000013871 bee wax Nutrition 0.000 claims description 3
- 239000012166 beeswax Substances 0.000 claims description 3
- 238000002156 mixing Methods 0.000 claims description 3
- 238000002360 preparation method Methods 0.000 claims description 3
- 238000003756 stirring Methods 0.000 claims description 3
- 238000004806 packaging method and process Methods 0.000 claims description 2
- 244000144977 poultry Species 0.000 claims description 2
- 235000013594 poultry meat Nutrition 0.000 claims description 2
- 241000736029 Ruvettus pretiosus Species 0.000 claims 1
- 238000009472 formulation Methods 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 239000004615 ingredient Substances 0.000 abstract description 2
- 208000027418 Wounds and injury Diseases 0.000 description 4
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 2
- 229940035676 analgesics Drugs 0.000 description 2
- 239000000730 antalgic agent Substances 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 238000013329 compounding Methods 0.000 description 2
- 230000005611 electricity Effects 0.000 description 2
- 239000010462 extra virgin olive oil Substances 0.000 description 2
- 235000021010 extra-virgin olive oil Nutrition 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- BQJCRHHNABKAKU-KBQPJGBKSA-N morphine Chemical compound O([C@H]1[C@H](C=C[C@H]23)O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4O BQJCRHHNABKAKU-KBQPJGBKSA-N 0.000 description 2
- 230000005855 radiation Effects 0.000 description 2
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 235000018062 Boswellia Nutrition 0.000 description 1
- 240000007551 Boswellia serrata Species 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- HEFNNWSXXWATRW-UHFFFAOYSA-N Ibuprofen Chemical compound CC(C)CC1=CC=C(C(C)C(O)=O)C=C1 HEFNNWSXXWATRW-UHFFFAOYSA-N 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 229920000175 Pistacia lentiscus Polymers 0.000 description 1
- 240000004350 Prunus spinosa Species 0.000 description 1
- 235000010829 Prunus spinosa Nutrition 0.000 description 1
- 206010042496 Sunburn Diseases 0.000 description 1
- 241000779819 Syncarpia glomulifera Species 0.000 description 1
- 206010053615 Thermal burn Diseases 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 229940125715 antihistaminic agent Drugs 0.000 description 1
- 239000000739 antihistaminic agent Substances 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- 229940049706 benzodiazepine Drugs 0.000 description 1
- 150000001557 benzodiazepines Chemical class 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 235000013601 eggs Nutrition 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 229960001680 ibuprofen Drugs 0.000 description 1
- 230000028709 inflammatory response Effects 0.000 description 1
- 239000003978 infusion fluid Substances 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000005722 itchiness Effects 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 229960005181 morphine Drugs 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000007383 nerve stimulation Effects 0.000 description 1
- 229940005483 opioid analgesics Drugs 0.000 description 1
- 229960005489 paracetamol Drugs 0.000 description 1
- 239000001739 pinus spp. Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 229940036248 turpentine Drugs 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/18—Sulfonamides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/35—Fat tissue; Adipocytes; Stromal cells; Connective tissues
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/57—Birds; Materials from birds, e.g. eggs, feathers, egg white, egg yolk or endothelium corneum gigeriae galli
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/64—Insects, e.g. bees, wasps or fleas
- A61K35/644—Beeswax; Propolis; Royal jelly; Honey
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
Definitions
- This invention is related to a bum cream/ointment used for the treatment of chemical bums besides first, second and third-degree burns.
- Burns are caused by various external sources which are classified as heat, chemical, electricity and radiation. Bum is a type of injury that occurs on the flesh or skin due to heat, electricity, chemicals, friction, or radiation. Burns that only affect the upper layer of the skin are defined as superficial or first-degree bums. Burns are sometimes referred to as partially thicker bums or second-degree burns when deeper layers are affected. In full thickness or third-degree burns, the burn affects all layers of the skin. In fourth-degree bums, the wound also affects deeper tissues such as muscle or bone.
- Burns can be very painful; many different options are available for pain treatment.
- analgesics such as ibuprofen and acetaminophen
- opioids such as morphine.
- Benzodiazepines may be used in addition to analgesics to reduce anxiety.
- antihistamines, massage, or transcutaneous nerve stimulation can be used to relieve the itchiness.
- a bum cream is mentioned within the patent document TR2008 / 02093 present in the current technique.
- the cream is a product made of egg yolk and olive oil to treat the bums on the skin and resolve the pain and cosmetic appearance of the skin.
- the patent document TR2012 / 10606 in the present technique refers to a burn treatment ointment.
- the document is related to an ointment with a herbal combination to be used in burn treatments.
- the ointment is obtained by compounding olive oil, beeswax, turpentine, boswellia, mastic gum, fir gum, blackthorn and orchanet root at certain ratios.
- the patent document TR2014 / 07106 includes information on the burn cream which is made of wax, olive oil and powder for therapeutic purposes to be used in second and third-degree skin bums, its substance properties, effects and amounts of active ingredients included are described.
- the objective of the invention is to create a burning cream/ointment to be used for the treatment of chemical bums, as well as first, second and third-degree burns. It is also desired that the cream will resolve the pain associated with burns rapidly.
- the bum cream developed to achieve the above-mentioned objectives includes; olive oil, wax, egg yolk oil, fish oil, diphenhydramine and sulphanilamide.
- the invention is a burn cream/ointment used in the treatment of first, second and third degree burns as well as chemical burns and includes olive oil, wax, egg yolk oil, fish oil (preferred whale oil), diphenhydramine and sulphanilamide.
- the invention is characterised as; being a burn cream/ointment used in the treatment of first, second and third degree burns as well as chemical bums; including olive oil, wax, egg yolk oil, fish oil (preferred whale oil), diphenhydramine and sulphanilamide and containing ingredients of 80-90% olive oil, 1-6% egg yolk oil , 2-8% fish oil (preferred whale oil), 3-9% wax, 0,02-0,1% diphenhydramine and 0,1 -0,5% sulphanilamide.
- the special compounding techniques include;
- the invention is applied by spreading on bums.
- the invention is effective for all types of bums. It is also used in sunburn and chemical burns. Within 45 minutes of application, there will be no pain and the risk of infection will be reduced. The wound won't blister. It does not leave burn marks even in third degree bums. In first-degree bums, complete healing takes up to 10 hours.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Biomedical Technology (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Insects & Arthropods (AREA)
- Zoology (AREA)
- Dermatology (AREA)
- Virology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Husbandry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Alternative & Traditional Medicine (AREA)
- Developmental Biology & Embryology (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Medicinal Preparation (AREA)
Abstract
The invention is characterised as; being a burn cream/ointment used in the treatment of first, second and third degree burns as well as chemical burns; including olive oil, wax, egg yolk oil, fish oil (preferred whale oil), diphenhydramine and sulphanilamide and containing ingredients of 80-90% olive oil, 1-6% egg yolk oil, 2-8% fish oil (preferred whale oil), 3-9% wax, 0,02-0,1% diphenhydramine and 0,1-0,5% sulphanilamide.
Description
Burn Treatment Cream and Production Method Thereof
Field of The Invention
This invention is related to a bum cream/ointment used for the treatment of chemical bums besides first, second and third-degree burns.
Background of The Invention
Burns are caused by various external sources which are classified as heat, chemical, electricity and radiation. Bum is a type of injury that occurs on the flesh or skin due to heat, electricity, chemicals, friction, or radiation. Burns that only affect the upper layer of the skin are defined as superficial or first-degree bums. Burns are sometimes referred to as partially thicker bums or second-degree burns when deeper layers are affected. In full thickness or third-degree burns, the burn affects all layers of the skin. In fourth-degree bums, the wound also affects deeper tissues such as muscle or bone.
The treatment required depends on the severity of the burn. While superficial burns can be treated with simple pain-killers, deeper bums may require longer treatment in special bum-treatment centres. Keeping the burnt area under cold water can relieve pain and reduce the wound formation, however prolonged exposure to cold can also decrease body temperature. Partially thicker burns may need to be cleaned and bandaged. Full thickness burns usually require surgical treatments such as skin grafting. In large bums, a high amount of intravenous fluid is usually required, because the inflammatory response of the body will result in significant fluid withdrawal from the capillary and oedema formation. The most common complications of burns are related to infection.
Burns can be very painful; many different options are available for pain treatment. These include the use of simple analgesics (such as ibuprofen and acetaminophen) and opioids such as morphine. Benzodiazepines may be used in addition to analgesics to reduce anxiety. During the healing process, antihistamines, massage, or transcutaneous nerve stimulation can be used to relieve the itchiness.
A bum cream is mentioned within the patent document TR2008 / 02093 present in the current technique. The cream is a product made of egg yolk and olive oil to treat the bums on the skin and resolve the pain and cosmetic appearance of the skin.
The patent document TR2012 / 10606 in the present technique however, refers to a burn treatment ointment. The document is related to an ointment with a herbal combination to be used in burn treatments. The ointment is obtained by compounding olive oil, beeswax, turpentine, boswellia, mastic gum, fir gum, blackthorn and orchanet root at certain ratios.
In the present technique, the patent document TR2014 / 07106 includes information on the burn cream which is made of wax, olive oil and powder for therapeutic purposes to be used in second and third-degree skin bums, its substance properties, effects and amounts of active ingredients included are described.
The Objective of The Invention
The objective of the invention is to create a burning cream/ointment to be used for the treatment of chemical bums, as well as first, second and third-degree burns. It is also desired that the cream will resolve the pain associated with burns rapidly.
The bum cream developed to achieve the above-mentioned objectives includes; olive oil, wax, egg yolk oil, fish oil, diphenhydramine and sulphanilamide.
Detailed Description of The Invention
The invention is a burn cream/ointment used in the treatment of first, second and third degree burns as well as chemical burns and includes olive oil, wax, egg yolk oil, fish oil (preferred whale oil), diphenhydramine and sulphanilamide.
The weight percentages of the substances are stated below;
• Olive Oil 80-90%
• Egg Yolk Oil 1-6%
• Fish Oil (preferred Whale Oil) 2-8%
• Wax 3-9%
• Diphenhydramine 0,02-0,1%
• Sulphanilamide 0,1 -0,5% Extra virgin olive oil is heated to at least l70°C -l80°C. When this temperature is reached, wax is added, and the added wax is melted by mixing. The heating is then terminated and egg yolk oil, fish oil (preferred whale oil), diphenhydramine and sulphanilamide are added. After stirring for 3-5 minutes, the preparation is allowed to rest for 6-7 hours. The ready-to-use ointment is then ready to be packaged.
Any kind of poultries can be used to obtain the oil of the egg yolk. Chicken eggs are preferred because they can be supplied easily. Also, any type of fish oil can be used as fish oil, however, the use of whale oil increases the effectiveness of the product.
The invention is characterised as; being a burn cream/ointment used in the treatment of first, second and third degree burns as well as chemical bums; including olive oil, wax, egg yolk oil, fish oil (preferred whale oil), diphenhydramine and sulphanilamide and containing ingredients of 80-90% olive oil, 1-6% egg yolk oil , 2-8% fish oil (preferred whale oil), 3-9% wax, 0,02-0,1% diphenhydramine and 0,1 -0,5% sulphanilamide.
Being a burn cream/ointment used in the treatment of first, second and third degree bums as well as chemical burns, the special compounding techniques include;
Heating the extra virgin olive oil of 80-90% weight to at least l70°C -l80°C.
When this temperature is reached, adding the 3-9% in weight of wax and melting it by mixing.
Terminating the heating and adding 1-6% egg yolk oil, 2-8% fish oil (preferred whale oil), 0,02-0,1% diphenhydramine and 0, 1-0,5% sulphanilamide.
Stirring for 3-5 minutes and allowing the preparation to rest for 6-7 hours.
Packaging the ready-to-use cream/ointment prepared.
The invention is applied by spreading on bums. The invention is effective for all types of bums. It is also used in sunburn and chemical burns. Within 45 minutes of application, there will be no pain and the risk of infection will be reduced. The wound won't blister. It does not leave burn marks even in third degree bums. In first-degree bums, complete healing takes up to 10 hours.
Claims
1. A burn cream/ointment used in the treatment of first, second and third degree burns as well as chemical burns characterised in that; it comprises olive oil, wax, egg yolk oil, fish oil (preferred whale oil), diphenhydramine and sulphanilamide.
2. A cream as mentioned in claim 1 wherein weight ratios of the components are characterized as; 80-90% olive oil, 1-6% egg yolk oil, 2-8% fish oil, 3- 9% wax, 0.02-0.1% diphenhydramine and 0.1-0.5% sulphanilamide.
3. A cream mentioned in claim 1 characterised in that; the fish oil listed in the formulation is whale oil.
4. A cream mentioned in claim 1 characterised in that; the egg yolk oil is obtained from poultries.
5. A method for the production of a burn cream/ointment used in the treatment of first, second and third degree burns as well as chemical bums, wherein following process steps are included;
The olive oil is heated up to at least least l70°C -l80°C.
Beeswax is added when this temperature is reached and added beeswax is melted by stirring,
- The heating operation is terminated and egg yolk oil fish oil (preferably whale oil), diphenhydramine and sulphanilamide are added,
The preparation is left for maturing for 6-7 hours after mixing for 3-5 minutes,
Packaging the ready-to-use cream/ointment prepared.
6. A production method mentioned in claim 5 characterised in that; it comprises 80-90% olive oil by weight.
7. A production method mentioned in claim 5 characterised in that; it comprises 1-6% egg yolk oil by weight.
8. A production method mentioned in claim 5 characterised in that; it
comprises 2-8% fish oil by weight.
9. It is the production method mentioned in claim 5 characterised in that; it comprises 3-9% wax by weight.
10. It is the production method mentioned in claim 5 characterised in that; it comprises 0,02-0,1% diphenhydramine by weight.
11. It is the production method mentioned in claim 5 characterised in that; it comprises 0, 1-0,5% sulphanilamide by weight.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TR2017/20999 | 2017-12-21 | ||
TR201720999 | 2017-12-21 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2019125313A1 true WO2019125313A1 (en) | 2019-06-27 |
Family
ID=66993672
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/TR2017/050736 WO2019125313A1 (en) | 2017-12-21 | 2017-12-30 | Burn treatment cream and production method thereof |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2019125313A1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2020188305A1 (en) * | 2019-03-18 | 2020-09-24 | Patsianidi Helen | Ointment for the treatment of burns |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB765600A (en) * | 1954-01-15 | 1957-01-09 | Drug Houses Of Australia Ltd | Salves for veterinary use |
US4748022A (en) * | 1985-03-25 | 1988-05-31 | Busciglio John A | Topical composition |
RU2010124992A (en) * | 2010-06-17 | 2011-12-27 | Закрытое акционерное общество "СНС-фарма" (RU) | MEDICINE FOR TREATMENT OF RAS, BURNS AND INFECTIOUS INFLAMMATORY DISEASES OF THE SKIN, APPLICATIONS OF THE SKIN AND Mucous membranes |
US20150313950A1 (en) * | 2012-12-10 | 2015-11-05 | Regenics As | Use of cellular extracts for skin rejuvenation |
US20160022676A1 (en) * | 2014-07-22 | 2016-01-28 | Meridian Research And Development, Inc. | Topical medications for bruises and burns |
-
2017
- 2017-12-30 WO PCT/TR2017/050736 patent/WO2019125313A1/en active Application Filing
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB765600A (en) * | 1954-01-15 | 1957-01-09 | Drug Houses Of Australia Ltd | Salves for veterinary use |
US4748022A (en) * | 1985-03-25 | 1988-05-31 | Busciglio John A | Topical composition |
RU2010124992A (en) * | 2010-06-17 | 2011-12-27 | Закрытое акционерное общество "СНС-фарма" (RU) | MEDICINE FOR TREATMENT OF RAS, BURNS AND INFECTIOUS INFLAMMATORY DISEASES OF THE SKIN, APPLICATIONS OF THE SKIN AND Mucous membranes |
US20150313950A1 (en) * | 2012-12-10 | 2015-11-05 | Regenics As | Use of cellular extracts for skin rejuvenation |
US20160022676A1 (en) * | 2014-07-22 | 2016-01-28 | Meridian Research And Development, Inc. | Topical medications for bruises and burns |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2020188305A1 (en) * | 2019-03-18 | 2020-09-24 | Patsianidi Helen | Ointment for the treatment of burns |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP3156065A1 (en) | Hydrolyzed fibroin-containing ointment and production method therefor | |
CN113597316A (en) | Lipid pharmaceutical preparation and application thereof | |
JP5900978B2 (en) | Skin wound healing composition and method for producing skin wound healing composition | |
WO2019125313A1 (en) | Burn treatment cream and production method thereof | |
US7141252B2 (en) | Composition for the treatment of burns, sunburns, abrasions, ulcers and cutaneous irritation | |
US8992995B2 (en) | Skin care ointment | |
CN110327412A (en) | A kind of tea oil-aloe cream and preparation method thereof | |
RU2163800C1 (en) | Burn ointment | |
RU2405536C2 (en) | Ointment for thermal injury treatment and method of treatment with it | |
US9968703B1 (en) | Burn wound composition and methods for treating burn wounds | |
JP6735489B2 (en) | Therapy Oil with Natural Ore Powder | |
US20230390176A1 (en) | Cosmetic Skin and Medical Cream | |
JP5781532B2 (en) | Pharmaceutical composition for treating skin burns | |
US20040146587A1 (en) | Topical composition for relief of pain and minor skin irritations | |
RU2248198C2 (en) | Anti-burn preparation | |
WO2021257027A1 (en) | An effective composition in healing wounds | |
RU2256441C1 (en) | Ointment for treatment of burn, suppurative and infected wound of different etiology and method for treatment of burn, suppurative and infected wound | |
JPH0413619A (en) | Local cooling agent for ambustion | |
GB2068223A (en) | Antiseptic ointment | |
CN1088367C (en) | Colour-restoring ointment for treating burn or scald | |
CN1052789A (en) | A kind of preparation method of ointment for treating burn | |
US9867775B2 (en) | Topical pharmaceutical bases for treating inflammatory disorders | |
RU2113212C1 (en) | Cream "uzhalin" | |
US20230056606A1 (en) | Cosmetic Skin Cream and Medicine | |
WO2017095352A1 (en) | Use of wax, olive oil, butter mixture and/ or its combination with varying ratios of boron and/ or derivatives thereof, in treatment of wounds, burns, and skin diseases |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 17935087 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 17935087 Country of ref document: EP Kind code of ref document: A1 |